272 related articles for article (PubMed ID: 33635409)
1. Margin Assessment and Re-excision Rates for Patients Who Have Neoadjuvant Chemotherapy and Breast-Conserving Surgery.
Cen C; Chun J; Kaplowitz E; Axelrod D; Shapiro R; Guth A; Schnabel F
Ann Surg Oncol; 2021 Sep; 28(9):5142-5148. PubMed ID: 33635409
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Neoadjuvant Chemotherapy on Margin Re-excision in Breast-Conserving Surgery.
Devane LA; Baban CK; O'Doherty A; Quinn C; McDermott EW; Prichard RS
World J Surg; 2020 May; 44(5):1547-1551. PubMed ID: 32002582
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
Woeste MR; Bhutiani N; Donaldson M; McMasters KM; Ajkay N
J Surg Oncol; 2021 Feb; 123(2):439-445. PubMed ID: 33259649
[TBL] [Abstract][Full Text] [Related]
4. A Single institution's randomized double-armed prospective study of lumpectomy margins with adjunctive use of the MarginProbe in nonpalpable breast cancers.
Geha RC; Taback B; Cadena L; Borden B; Feldman S
Breast J; 2020 Nov; 26(11):2157-2162. PubMed ID: 32772474
[TBL] [Abstract][Full Text] [Related]
5. MarginProbe© reduces the rate of re-excision following breast conserving surgery for breast cancer.
Blohmer JU; Tanko J; Kueper J; Groß J; Völker R; Machleidt A
Arch Gynecol Obstet; 2016 Aug; 294(2):361-7. PubMed ID: 26796680
[TBL] [Abstract][Full Text] [Related]
6. Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome.
van Hemert A; van Loevezijn AA; Bosman A; Vlahu CA; Loo CE; Peeters MTFDV; van Duijnhoven FH; van der Ploeg IMC
Breast Cancer Res Treat; 2024 Apr; 204(3):497-507. PubMed ID: 38189904
[TBL] [Abstract][Full Text] [Related]
7. The Relationship of Breast Density and Positive Lumpectomy Margins.
Gooch JC; Yoon E; Chun J; Kaplowitz E; Jubas T; Guth A; Axelrod D; Shapiro R; Darvishian F; Schnabel F
Ann Surg Oncol; 2019 Jun; 26(6):1729-1736. PubMed ID: 30888516
[TBL] [Abstract][Full Text] [Related]
8. Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ.
Laws A; Brar MS; Bouchard-Fortier A; Leong B; Quan ML
J Surg Oncol; 2018 Dec; 118(7):1205-1211. PubMed ID: 30293241
[TBL] [Abstract][Full Text] [Related]
9. Use of MarginProbe as an adjunct to standard operating procedure does not significantly reduce re-excision rates in breast conserving surgery.
LeeVan E; Ho BT; Seto S; Shen J
Breast Cancer Res Treat; 2020 Aug; 183(1):145-151. PubMed ID: 32607640
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors associated with involved margins in breast cancer treated with neoadjuvant chemotherapy followed by breast-conserving therapy.
Davoine E; Dion L; Nyangoh Timoh K; Beraud E; Tas P; Tavenard A; Laviolle B; Perrin C; Foucher F; Levêque J; Lavoué V
J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):467-472. PubMed ID: 31207391
[TBL] [Abstract][Full Text] [Related]
11. Impact of consensus guidelines for breast-conserving surgery in patients with ductal carcinoma in situ.
Tremelling A; Aft RL; Cyr AE; Gillanders WE; Glover-Collins K; Herrmann V; Margenthaler JA
Cancer Rep (Hoboken); 2022 May; 5(5):e1502. PubMed ID: 34245135
[TBL] [Abstract][Full Text] [Related]
12. Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgery.
Yu CC; Chiang KC; Kuo WL; Shen SC; Lo YF; Chen SC
Breast; 2013 Oct; 22(5):698-702. PubMed ID: 23333255
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic factors related to surgical margin involvement, reoperation, and residual cancer in primary operable breast cancer - An analysis of 2050 patients.
Lai HW; Huang RH; Wu YT; Chen CJ; Chen ST; Lin YJ; Chen DR; Lee CW; Wu HK; Lin HY; Kuo SJ
Eur J Surg Oncol; 2018 Nov; 44(11):1725-1735. PubMed ID: 30120037
[TBL] [Abstract][Full Text] [Related]
14. Predictors of re-excision among women undergoing breast-conserving surgery for cancer.
Waljee JF; Hu ES; Newman LA; Alderman AK
Ann Surg Oncol; 2008 May; 15(5):1297-303. PubMed ID: 18259820
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing suboptimal pathologic margins and re-excision following breast conserving surgery for ductal carcinoma in-situ.
Dhak S; Baliski C; Bakos B
Am J Surg; 2023 May; 225(5):866-870. PubMed ID: 36894415
[TBL] [Abstract][Full Text] [Related]
16. Surgeon Volume, Patient Age, and Tumor-Related Factors Influence the Need for Re-Excision After Breast-Conserving Surgery.
Hughes L; Hamm J; McGahan C; Baliski C
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):656-664. PubMed ID: 27718033
[TBL] [Abstract][Full Text] [Related]
17. Short term safety of oncoplastic breast conserving surgery for larger tumors.
Wijgman DJ; Ten Wolde B; van Groesen NR; Keemers-Gels ME; van den Wildenberg FJ; Strobbe LJ
Eur J Surg Oncol; 2017 Apr; 43(4):665-671. PubMed ID: 28041648
[TBL] [Abstract][Full Text] [Related]
18. Impact of cavity shaving on residual tumor rates in patients with primary invasive carcinoma and carcinoma in situ in breast conserving surgery.
Fernández-Pacheco M; Gerken M; Ortmann O; Ignatov A; Klinkhammer-Schalke M; Hatzipanagiotou ME; Inwald EC
Arch Gynecol Obstet; 2023 May; 307(5):1573-1583. PubMed ID: 36282347
[TBL] [Abstract][Full Text] [Related]
19. Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization.
Cartagena LC; McGuire K; Zot P; Pillappa R; Idowu M; Robila V
Clin Breast Cancer; 2021 Oct; 21(5):e594-e601. PubMed ID: 33814286
[TBL] [Abstract][Full Text] [Related]
20. Margin assessment before intraoperative radiotherapy during breast conserving surgery-Does the addition of MarginProbe decrease the need for addition of fractionated whole breast radiation?
Hermann N; Haas I; Malinger P; Kaufman Z
Breast J; 2020 Jul; 26(7):1343-1346. PubMed ID: 32367618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
